FDA OKs arthritis gel, allergy eyedrops for over-the-counter sales


<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Three prescription drugs have been approved for status US Food and Drug Administration announced Friday. "data-reactid =" 11 "> Three prescription drugs have been approved for over-the-counter status, the US Food and Drug Administration announced on Friday.

According to the FDA, the first drug, Voltaren Arthritis Pain from GlaxoSmithKline, is a topical gel that relieves arthritis pain, especially on the joints of the hands, knees and feet. It was first approved as a prescription drug in 2007.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "FDA RECALLS INJURY AND DEATH-RELATED INSULIN PUMPS"data-reactid =" 13 ">FDA RECALLS INJURY AND DEATH-RELATED INSULIN PUMPS

The others are Pataday d & # 39; Alcon once and twice a day, a solution of eye drops that relieves itching and red eyes caused by pollen, ragweed, weed, animal hair or dander. The prescription drug was first approved in 1996 under the name of Patanol. It prevents the release of histamine to control allergies.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "START FOX BUSINESS BY CLICKING HERE"data-reactid =" 15 ">START FOX BUSINESS BY CLICKING HERE

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "MOBILE PHONES DO NOT CAUSE CANCER, FDA SAYS"data-reactid =" 16 ">MOBILE PHONES DO NOT CAUSE CANCER, FDA SAYS

Over-the-counter drugs will no longer be available as prescription drugs, according to the FDA.

Many products sold without a prescription today were only available by prescription 30 years ago, according to Karen Mahoney, Acting Assistant Director of the FDA's Bureau of Nonprescription Drugs. But the same approval process has made them more widely available.

"The approval of a wider range of over-the-counter drugs has the potential to improve public health by increasing the types of drugs that consumers can access and use that would otherwise only be available on order, "Mahoney said in a press release. "This includes the daily non-prescription access of millions of people with arthritis-related joint pain to another non-opioid treatment option."

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "CLICK HERE TO LEARN MORE ABOUT FOX BUSINESS"data-reactid =" 20 ">CLICK HERE TO LEARN MORE ABOUT FOX BUSINESS

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Related Articles"data-reactid =" 21 ">Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *